Methotrexate Injection and Dexibuprofen: Interaction Details
- Methotrexate Injection
- OtrexupRasuvoReditrex +6 more
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Methotrexate Injection and Dexibuprofen interaction:
Methotrexate Injection
- Otrexup
- Rasuvo
- Reditrex
- Abitrexate
- Folex
- Mexate
- Xatmep
- Jylamvo
- Trexall
Dexibuprofen
We don't have a drug information page for Dexibuprofen yet. Have a question about Dexibuprofen? Ask a pharmacist, free →
What Happens When You Take Methotrexate Injection With Dexibuprofen
What can happen when they are taken together (rated Major)
Increased methotrexate exposure, an increased risk of methotrexate-related severe adverse reactions, reduced active formation and possibly reduced methotrexate
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Taking together with methotrexate can raise methotrexate exposure, and that rise may heighten the likelihood of serious methotrexate adverse reactions. In certain cases, the combination may also lower the formation of active metabolites, which could diminish the clinical effectiveness of methotrexate.1
As a general rule, NSAIDs should not be given before or at the same time as high-dose methotrexate (that is, the doses used in cancer therapy), because this can increase and extend methotrexate exposure and raise the risk of methotrexate toxicities. and hematological toxicities, some severe and some fatal, have been reported when NSAIDs were given with methotrexate (usually at high doses).
Many patients have tolerated low-dose methotrexate (that is, the 7.5 to 15 mg/week used for arthritis) given with NSAIDs, but caution is still recommended. The combination of NSAIDs with higher methotrexate doses, such as those used for psoriasis, has not been fully evaluated.2 When the combination cannot be avoided, patients should be closely monitored for methotrexate adverse reactions.1
The Methotrexate Injection and Dexibuprofen Interaction, Explained
Dexibuprofen is an pain reliever, similar to ibuprofen. When it is taken with methotrexate, it can make your body hold on to more methotrexate for longer. That can raise the chance of serious side effects, like mouth sores, stomach problems, or low blood cell counts. This matters most with high-dose methotrexate (the kind used for cancer). Low-dose methotrexate (like for arthritis) has been well tolerated with in many people, but caution is still advised.
Please don't stop or change anything on your own. Tell your pharmacist or doctor you take both. They can decide if it is a good fit for you, adjust doses if needed, and keep a closer eye on you.
Methotrexate + dexibuprofen (): Established, major, delayed onset.
- Mechanism: may reduce methotrexate , decrease (reduced renal prostaglandin-mediated perfusion and tubular secretion), and displace methotrexate from protein binding. Net effect is increased and prolonged methotrexate exposure (higher ), raising risk of and hematologic toxicity. Reduced active formation may lessen in some cases.
- Magnitude: Severe and sometimes fatal toxicity reported, usually with high-dose methotrexate.
- Management: Avoid NSAIDs before or with high-dose methotrexate. Low-dose (7.5 to 15 mg/week) is often tolerated, but use caution. Psoriasis-range doses are not well studied. If unavoidable, monitor closely for methotrexate adverse reactions (CBC, renal function, GI toxicity).
See the 16 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Methotrexate Injection and Dexibuprofen Interact
The likely mechanism
Reduced methotrexate ; reduced of methotrexate; protein binding displacement
How to Manage the Methotrexate Injection and Dexibuprofen Interaction
Your care team can often manage this by tailoring your methotrexate dose and watching you more closely.
- With high-dose methotrexate (cancer treatment), like dexibuprofen are generally avoided around the time of treatment.
- With low-dose methotrexate (such as for arthritis), the combination is often tolerated, but your team may use caution and monitor you more closely.
- Keep taking your medicines as prescribed unless your prescriber tells you otherwise.
- Tell your pharmacist or prescriber about all pain relievers you use, including over-the-counter ones.
- Report mouth sores, unusual bruising or bleeding, fever, stomach pain, or black stools right away.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Methotrexate Injection or Dexibuprofen need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
11 reports from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Effect of aspirin and sulindac on methotrexate clearance
The of low dose methotrexate were assessed in 12 rheumatoid arthritis patients with and without chronic dosing of aspirin or sulindac. All patients had received methotrexate for at least 1 year and had been on a stable dose for at least 2 months before the study.
A 3-way crossover design was used, in which patients received aspirin 45 to 50 mg/kg/day divided into 3 daily doses for 16 days, sulindac 200 mg every 12 hours for 16 days, or no . On day 14, methotrexate 10 mg/m(2) was given as an IV bolus and were measured.
Methotrexate did not differ among the 3 treatments. However, the of the active 7-OH-methotrexate was increased, indicating exposure to the metabolite for a longer period with sulindac and to a greater extent with aspirin.
The significance of this metabolite in rheumatoid arthritis treatment is not completely understood, but it is thought to have some cytotoxic activity and to be able to induce damage. Until the significance of 7-OH-methotrexate's activity and the effect of prolonged exposure to it are known, these nonsteroidal antiinflammatory agents, especially aspirin, should be used with caution in combination with methotrexate.3
-
Report 2 · Study title
Aspirin alters methotrexate disposition in rheumatoid arthritis patients
In 15 rheumatoid arthritis patients receiving oral aspirin (3900 mg/day) and low-dose IV methotrexate (10 mg), the unbound fraction of methotrexate was higher, while systemic and of methotrexate were lower. Single-dose disposition studies were carried out before and after 1 week of aspirin therapy. No hematologic, renal, or toxicity was observed.4
-
Report 3 · Study title
Coadministration of naproxen and low-dose methotrexate in patients with rheumatoid arthritis
No effect of naproxen on the disposition of low-dose methotrexate was demonstrated in 12 rheumatoid arthritis patients with normal function. Patients received oral or IV methotrexate 15 mg, alone or together with naproxen 1000 mg daily.
Naproxen did not statistically alter the systemic , renal clearance, or protein binding of methotrexate. Methotrexate toxicity was not evident either with or without naproxen.5
-
Report 4 · Study title
Lack of significant interaction between low dose methotrexate and ibuprofen or flurbiprofen in patients with arthritis
In 6 patients with rheumatoid arthritis, no interaction was observed between low-dose methotrexate and either ibuprofen 800 mg 3 times daily or flurbiprofen 100 mg 3 times daily, in terms of , , time to peak , or . Assessments were done 48 hours before dosing and after 6 days of NSAID treatment, with the methotrexate dose kept fixed.
Results were similar after oral and IM methotrexate. All patients had normal function and none were taking .6 In patients stabilized on methotrexate for at least 3 months, 6 days of treatment with flurbiprofen 3 mg/kg/day, ketoprofen 3 mg/day, or piroxicam 20 mg/day produced no change in methotrexate (oral or renal), unbound fraction, or amount excreted unchanged.7
-
Report 5 · Study title
Methotrexate-nonsteroidal antiinflammatory drug interaction in children with arthritis
The interaction between methotrexate and several (tolmetin, indomethacin, naproxen, and aspirin) was examined in 7 children with chronic arthritis. In all 7 patients, the average of methotrexate was significantly prolonged when given with an , whereas methotrexate , , and volume of distribution did not change significantly.
Although changes in methotrexate clearance were not statistically significant, they varied widely. In 6 of 7 patients, AUC rose by 19% to 140%, which suggests that some children may have clinically significant increases in methotrexate levels with NSAID use.8
-
Report 6 · Study title
Diclofenac: a reappraisal
Severe, at times fatal, toxicity has resulted from of diclofenac and methotrexate in patients with rheumatoid arthritis or malignant neoplasms. Diclofenac and other seem to inhibit of methotrexate, which leads to toxic serum methotrexate concentrations. administration should be avoided.9
-
Report 7 · Study title
Serious methotrexate toxicity caused by interaction with ibuprofen (letter)
Severe toxicity was reported with high-dose methotrexate (12 g) and ibuprofen 400 mg every 4 hours in an 18-year-old man with osteogenic sarcoma. Twenty hours after the start of a 6 hour methotrexate infusion, his serum creatinine was 2.3 mg/dL and his methotrexate level was 1.8 x 10(-4) M.
Sixty-eight hours after the infusion, serum creatinine was 3.5 mg/dL. Immediate, intensive rescue with folinic acid and thymidine brought the serum creatinine to 1.6 mg/dL at hour 284.10
-
Report 8 · Study title
Clinical and pharmacokinetic evidence of a life-threatening interaction between methotrexate and ketoprofen
ketoprofen and high-dose methotrexate 800 to 8300 mg/m(2) has led to severe methotrexate toxicity and death. Among 36 patients who received 118 cycles of high-dose methotrexate, ketoprofen was given at the same time in 4 cycles, and all 4 were associated with severe methotrexate toxicity, with fatality in 3 cases.
A mechanism was proposed for the interaction, possibly involving ketoprofen of renal prostaglandin synthesis, causing reduced renal perfusion and inhibited methotrexate . Competitive renal secretion was also suggested. In another patient in this series, diclofenac was associated with severe methotrexate toxicity, and other may also be implicated in this reaction.11
-
Report 9 · Study title
Thrombocytopenia after a single test dose of methotrexate
A 36 year-old woman with juvenile rheumatoid arthritis had sarcoidosis with worsening cutaneous lesions. Her arthritis was treated with ibuprofen 600 mg three times daily.
Laboratory studies showed no sign of insufficiency or abnormal serum albumin, and her count was 195,000/mm(3). One week after her first oral methotrexate 7.5 mg dose, she noticed prolonged bleeding after a superficial laceration, along with multiple petechiae.
Four days later her platelet count was 25,000/mm(3). Ibuprofen and methotrexate were both stopped, and nine days later her platelet count was 185,000/mm(3).15
-
Report 10 · Study title
Clinical and pharmacokinetic evidence of a life-threatening interaction between methotrexate and ketoprofen
-
Report 11 · Study title
Methotrexate and nonsteroidal antiinflammatory drug interactions
A 74-year-old woman had been treated for 3 years with methotrexate 2.5 mg three times a week for rheumatoid arthritis. Flurbiprofen 100 mg per day was then added to her regimen.
One to two weeks later, she was hospitalized for one week with hematemesis, diarrhea with melena, nausea, and weakness. Other medications at admission were folic acid, digoxin, gemfibrozil, iron supplements, and dipyridamole.
Acute bleeding was found. She was also diagnosed with anemia, , and secondary to methotrexate therapy.16
Methotrexate Injection and Dexibuprofen: Common Questions
How serious is the Methotrexate Injection and Dexibuprofen interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Methotrexate Injection and Dexibuprofen interaction managed?
Your care team can often manage this by tailoring your methotrexate dose and watching you more closely. With high-dose methotrexate (cancer treatment), like dexibuprofen are generally avoided around the time of treatment. With low-dose methotrexate (such as for arthritis), the combination is often tolerated, but your team may use caution and monitor you more closely. Keep taking your medici… Management is individual — always follow your own care team's guidance.
Who is at higher risk from the Methotrexate Injection and Dexibuprofen interaction?
The interaction record names this group as more likely to be affected:
- People taking higher doses
If this describes you, tell your pharmacist or prescriber.
How quickly could this interaction happen?
The documented onset is "delayed". Effects tend to build up gradually over days to weeks.
How strong is the evidence for this interaction?
The evidence is graded "established". Well documented — supported by controlled studies or strong clinical data.
Ask About the Methotrexate Injection and Dexibuprofen Interaction
Ask in your own words about taking Methotrexate Injection and Dexibuprofen together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (16)
- Product Information: JYLAMVO oral solution, methotrexate oral solution. Shorla Oncology Inc (per FDA), Cambridge, MA, 2024. DailyMed
- Product Information: OTREXUP(TM) subcutaneous injection solution, methotrexate subcutaneous injection solution. Antares Pharma, Inc. (per manufacturer), Ewing, NJ, 2013. DailyMed
- Furst DE, Herman RA, Koehnke R, et al: Effect of aspirin and sulindac on methotrexate clearance. J Pharm Sci 1990; 79:782-786. PubMed
- Stewart CF, Fleming RA, Germain BF, et al: Aspirin alters methotrexate disposition in rheumatoid arthritis patients. Arthritis Rheum 1991; 34:1514-1520. DOI
- Stewart CF, Fleming RA, Arkin CR, et al: Coadministration of naproxen and low-dose methotrexate in patients with rheumatoid arthritis. Clin Pharmacol Ther 1990; 47:540-546. PubMed
- Skeith KJ, Russell AS, Jamali F, et al: Lack of significant interaction between low dose methotrexate and ibuprofen or flurbiprofen in patients with arthritis. J Rheumatol 1990; 17:1008-1010.
- Tracy TS, Worster T, Bradley JD, et al: Methotrexate disposition following concomitant administration of ketoprofen, piroxicam and flurbiprofen in patients with rheumatoid arthritis. Br J Clin Pharmacol 1994; 37:453-456. PubMed
- Dupuis LL, Shore A, Silverman ED, et al: Methotrexate-nonsteroidal antiinflammatory drug interaction in children with arthritis. J Rheumatol 1990; 17:1469-1473.
- Todd PA & Sorkin EM: Diclofenac: a reappraisal. Drugs 1988; 35:244-285.
- Cassano WF: Serious methotrexate toxicity caused by interaction with ibuprofen (letter). Am J Pediatr Hematol Oncol 1989; 11:481-482.
- Thyss A, Milano G, Kubar J, et al: Clinical and pharmacokinetic evidence of a life-threatening interaction between methotrexate and ketoprofen. Lancet 1986; 1:256-258. PubMed
- Daly H, Boyle J, Roberts C, et al: Interaction between methotrexate and non-steroidal anti-inflammatory drugs. Lancet 1986; 1:559. DOI
- Maiche AG: Acute renal failure due to concomitant action of methotrexate and indomethacin (letter). Lancet 1986; 1:1390. PubMed
- Singh RR, Malaviya AN, Pandey JN, et al: Fatal interaction between methotrexate and naproxen (letter). Lancet 1986; 1:1390. DOI
- Jih DM & Werth VP: Thrombocytopenia after a single test dose of methotrexate. J Am Acad Dermatol 1998; 39:349-351. PubMed
- Frenia ML & Long KS: Methotrexate and nonsteroidal antiinflammatory drug interactions. Ann Pharmacother 1992; 26:234-237. DOI
Other Serious Interactions of Methotrexate Injection and Dexibuprofen
Also serious with Methotrexate Injection
Also serious with Dexibuprofen
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data. This interaction.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks. This interaction.
- UnspecifiedThe timing of this interaction is not well characterized.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.